Phase III Study of Vincristine Sulfate Liposome For Injection In Adults With Naïve Acute Lymphoblastic Leukemia

NCT02072785 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

480

Enrollment

INDUSTRY

Sponsor class

Conditions

Adult Acute Lymphoblastic Leukemia

Interventions

DRUG: Vincristine Sulfate Liposome
DRUG: Vincristine Sulfate

Sponsor

Nanjing Luye Sike Pharmaceutical Co., Ltd.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]